Literature DB >> 10781620

Ceftriaxone-resistant salmonella infection acquired by a child from cattle.

P D Fey1, T J Safranek, M E Rupp, E F Dunne, E Ribot, P C Iwen, P A Bradford, F J Angulo, S H Hinrichs.   

Abstract

BACKGROUND: The emergence of resistance to antimicrobial agents within the salmonellae is a worldwide problem that has been associated with the use of antibiotics in livestock. Resistance to ceftriaxone and the fluoroquinolones, which are used to treat invasive salmonella infections, is rare in the United States. We analyzed the molecular characteristics of a ceftriaxone-resistant strain of Salmonella enterica serotype typhimurium isolated from a 12-year-old boy with fever, abdominal pain, and diarrhea.
METHODS: We used pulsed-field gel electrophoresis and analysis of plasmids and beta-lactamases to compare the ceftriaxone-resistant S. enterica serotype typhimurium from the child with four isolates of this strain obtained from cattle during a local outbreak of salmonellosis.
RESULTS: The ceftriaxone-resistant isolate from the child was indistinguishable from one of the isolates from cattle, which was also resistant to ceftriaxone. Both ceftriaxone-resistant isolates were resistant to 13 antimicrobial agents; all but one of the resistance determinants were on a conjugative plasmid of 160 kb that encoded the functional group 1 beta-lactamase CMY-2. Both ceftriaxone-resistant isolates were closely related to the three other salmonella isolates obtained from cattle, all of which were susceptible to ceftriaxone.
CONCLUSIONS: This study provides additional evidence that antibiotic-resistant strains of salmonella in the United States evolve primarily in livestock. Resistance to ceftriaxone, the drug of choice for invasive salmonella disease, is a public health concern, especially with respect to children, since fluoroquinolones, which can also be used to treat this disease, are not approved for use in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781620     DOI: 10.1056/NEJM200004273421703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  120 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

Review 2.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 4.  Antibiotics in agriculture: when is it time to close the barn door?

Authors:  Marc Lipsitch; Randall S Singer; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

5.  Characterization of multiple-antimicrobial-resistant salmonella serovars isolated from retail meats.

Authors:  Sheng Chen; Shaohua Zhao; David G White; Carl M Schroeder; Ran Lu; Hanchun Yang; Patrick F McDermott; Sherry Ayers; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

6.  Thermal inactivation of susceptible and multiantimicrobial-resistant salmonella strains grown in the absence or presence of glucose.

Authors:  R T Bacon; J R Ransom; J N Sofos; P A Kendall; K E Belk; G C Smith
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

7.  Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases.

Authors:  Jennifer A Black; Kenneth S Thomson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Jiunn-Jong Wu; Shu-Huei Tsai; Chin-Luan Chuang
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Authors:  Laurent Poirel; Claire Héritier; Colette Spicq; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada.

Authors:  Frank M Aarestrup; Henrik Hasman; Inger Olsen; Gitte Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.